Charles Huang - 17 Mar 2026 Form 3 Insider Report for ZTO Express (Cayman) Inc. (ZTO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
17 Mar 2026, 06:07:35 UTC
Next SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ HUANG CHARLES

Key filing fact

Charles Huang filed Form 3 for ZTO Express (Cayman) Inc. (ZTO) on 17 Mar 2026.

Key facts

  • This page summarizes Charles Huang's Form 3 filing for ZTO Express (Cayman) Inc. (ZTO).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Mar 2026, 06:07.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001163438 Primary reporting owner

HUANG CHARLES

Relationship
Director
Address
BUILDING ONE, NO. 1685 HUAZHI ROAD, SHANGHAI, CHINA
Signature
/s/ HUANG CHARLES
Signature date
17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZTO holding

American depositary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
18,448
Date
17 Mar 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each represents one Class A ordinary share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .